MEDNAX, INC. (NYSE:MD) Files An 8-K Results of Operations and Financial Condition

Item2.02

On May4, 2017, MEDNAX, Inc., a Florida corporation (the Company),
issued a press release announcing the results of its operations
for the three months ended March31, 2017 (the First Quarter
Release).A copy of the First Quarter Release is attached hereto
as Exhibit 99.1 and is hereby incorporated in this Current Report
by reference.The information contained in this Item2.02,
including Exhibit 99.1, shall not be deemed filed with the
Securities and Exchange Commission nor incorporated by reference
in any registration statement or other document filed by the
Company under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such
filing.

99.1Press Release of MEDNAX, Inc. dated May4, 2017.

About MEDNAX, INC. (NYSE:MD)

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.

MEDNAX, INC. (NYSE:MD) Recent Trading Information

MEDNAX, INC. (NYSE:MD) closed its last trading session down -0.38 at 60.43 with 1,357,740 shares trading hands.